The Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics

Sadeleştirilmiş öğe sayfası
dc.contributor.authorErgene, Oktay
dc.contributor.authorAras, Dursun
dc.contributor.authorKaymaz, Cihangir
dc.contributor.authorArsava, Ethem Murat
dc.contributor.authorGonen, Can
dc.contributor.authorGurkas, Erdem
dc.contributor.authorArslan, Ugur
dc.contributor.authorCagirici, Goksel
dc.contributor.authorCay, Serkan
dc.contributor.authorKilickap, Mustafa
dc.contributor.authorKanat, Selcuk
dc.contributor.authorOzpelit, Ebru
dc.contributor.authorVatansever, Fahriye
dc.contributor.authorKilickesmez, Kadriye
dc.date.accessioned2025-10-16T15:17:09Z
dc.date.issued2022
dc.identifier.doi10.5543/tkda.2022.21191
dc.identifier.otherWOS:000834873000022
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6868
dc.publisherKARE PUBL
dc.sourceTURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY
dc.subjectApixaban
dc.subjectdabigatran
dc.subjectDOACs
dc.subjectedoxaban
dc.subjectNOACs
dc.subjectrivaroxaban
dc.titleThe Role of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Atrial Fibrillation: Treatment Management Based on Patient and Drug Characteristics
dc.typeReview

Dosyalar

Koleksiyonlar

WOS